39 completed, 18 unknown, 11 recruiting, 10 active not recruiting. 53 Not applicable, 6 Phase 3, 3 Phase 2, 1 Early Phase 1, 1 Phase 4.
Follow Mammography: new trials by email Literature Review of Mammography trials Research Report on Mammography
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis Biopsy Procedure, Biospecimen Collection, Breast Conservation Treatment - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma | Phase 3 | Recruiting | SWOG Cancer Research Network | 562 | 2027-03-09 | 2026-10-13 |
| Artificial Intelligence Integration in Breast Cancer Screening: The ANIHTA Study Artificial intelligence-based software for mammography, Discrete Choice Experiment on AI-Supported Breast Cancer Screening - Breast Neoplasms | Not yet recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 200075 | 2026-11-01 | 2026-10-19 | |
| Precision Supplemental Imaging in Women With Dense Breasts Prognosia Breast, Mammogram, MRI - Breast Cancer, Cancer of the Breast | Not applicable | Recruiting | Washington University School of Medicine | 78 | 2026-09-09 | 2026-09-16 |
| ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab Trastuzumab (Herceptin), Pertuzumab, Echocardiography - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 3 | Recruiting | Alliance for Clinical Trials in Oncology | 1524 | 2025-09-17 | 2026-10-02 |
| Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction Biospecimen Collection, Mammography, Omega-3-Acid Ethyl Esters - Breast Atypical Hyperplasia, Breast Carcinoma | Phase 2 | Recruiting | National Cancer Institute (NCI) | 66 | 2025-07-28 | 2026-08-04 |
| Early Detection of Breast Cancer Among Syrian Women Mammogram - Breast Cancer Detection | Enrolling by invitation | Al-Hawash Private University | 1000 | 2025-05-17 | 2025-07-18 | |
| The Added Value of DBT Over Mammography in Local Tumor Staging in Patients With BIRADS 4 or 5 Lesions digital breast tomosynthesis and mammography - Digital Breast Tomosynthesis | Not yet recruiting | Assiut University | 64 | 2025-02-28 | 2025-03-03 | |
| Contrast Enhancement Mammography vs MRI for the Surveillance of Women at High Risk of Breast Cancer: Con-trust Randomized Controlled Trial Contrast Enhancement Mammography, magnetic resonance imaging (MRI) and digital mammography (DM) - Breast Cancer Screening and Diagnosis | Not applicable | Recruiting | Azienda USL Reggio Emilia - IRCCS | 2200 | 2025-02-01 | 2026-05-07 |
| Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems Digital Breast Tomosynthesis (DBT) - Architectural Distortions, Breast Tomosynthesis | Recruiting | M.D. Anderson Cancer Center | 100 | 2024-10-18 | 2026-10-07 | |
| Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer Acolbifene Hydrochloride, Biospecimen Collection, Mammography - Breast Atypical Hyperplasia, Breast Carcinoma | Phase 2 | Recruiting | National Cancer Institute (NCI) | 80 | 2024-10-10 | 2026-07-07 |
| Value of Digital Breast Tomosynthesis in Breast Lesions Digital breast tomosynthesis - Digital Breast Tomosynthesis | Not applicable | Active not recruiting | Sohag University | 50 | 2024-10-09 | 2024-11-14 |
| Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial Biopsy Procedure, Biospecimen Collection, Mammography - Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia | Phase 2 | Recruiting | National Cancer Institute (NCI) | 200 | 2024-09-27 | 2026-07-27 |
| Transgender and Gender Diverse Individuals Screening for Breast Cancer Mammography and Breast Ultrasound - Breast Cancer | Not applicable | Active not recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1600 | 2024-05-01 | 2025-03-13 |
| Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer Biospecimen Collection, Cyclophosphamide, Doxorubicin - Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | Phase 3 | Recruiting | National Cancer Institute (NCI) | 3680 | 2023-11-27 | 2026-10-29 |
| Digital Breast Tomosynthesis for the Dutch National Breast Cancer Screening Program Digital Breast Tomosynthesis - Breast Cancer Screening | Not applicable | Active not recruiting | Radboud University Medical Center | 18200 | 2023-07-17 | 2025-07-29 |
| Clinical Data Collection in Breast Tomosynthesis (COBRIS) Breast Tomosynthesis - Breast Cancer | Not applicable | Unknown | GE Healthcare | 150 | 2023-02-15 | 2023-06-22 |
| Weight Loss and Breast Cancer mammography - Breast Cancer, Obesity, Morbid | Unknown | Fatih Sultan Mehmet Training and Research Hospital | 300 | 2022-12-15 | 2022-12-16 | |
| Evaluating the Use of Magnetic Resonance Imaging and Contrast Enhanced Mammography After MagTrace® Use MRI - Breast Cancer | Unknown | Zuyderland Medisch Centrum | 25 | 2022-11-23 | 2022-12-05 | |
| Artificial Intelligence in Breast Cancer Screening Programs Mammograms - Breast Cancer, Screening | Not applicable | Completed | Maimónides Biomedical Research Institute of Córdoba | 31301 | 2022-03-15 | 2025-08-14 |
| Prospective Case Collection Study for New Mammography Technologies Mammography - Mammography | Not applicable | Active not recruiting | Hologic, Inc. | 7500 | 2021-12-10 | 2026-06-22 |
Showing 20 of 88. Sign in to see all of them.
Breast Neoplasms (64) · Carcinoma, Intraductal, Noninfiltrating (8) · Breast Carcinoma In Situ (5) · Disease (5) · Obesity (2) · Triple Negative Breast Neoplasms (2) · Wrist Fractures (2) · Acquired Immunodeficiency Syndrome (1) · Colorectal Neoplasms (1) · Coronary Artery Disease (1) · Cysts (1) · Emergencies (1) · Fibrocystic Breast Disease (1) · Fractures, Bone (1) · Hip Fractures (1)
GE Healthcare (8) · Fujifilm Medical Systems USA, Inc. (5) · National Cancer Institute (NCI) (4) · Alliance for Clinical Trials in Oncology (3) · Azienda USL Reggio Emilia - IRCCS (3) · Hologic, Inc. (3) · Assiut University (2) · Chinese University of Hong Kong (2) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2) · M.D. Anderson Cancer Center (2) · Massachusetts General Hospital (2) · Peking Union Medical College Hospital (2) · Seno Medical Instruments Inc. (2) · University of Southern California (2) · Washington University School of Medicine (2)
United States (51) · Italy (10) · Canada (5) · China (4) · France (3) · Germany (2) · Hong Kong (2) · Netherlands (2) · Puerto Rico (2) · Spain (2) · Taiwan (2) · Egypt (1) · Nigeria (1) · South Korea (1) · Syria (1)
Robert M Uzenoff (4) · A. Thomas Stavros, MD (1) · Abass Alavi, MD (1) · Adeleye D Omisore, MBBS, M.Sc, FWACS, FMCR (1) · Adrienne Waks, MD (1) · Agnes Lazar (1) · Alberto S Tagliafico, MD (1) · Alfonso Frigerio, Dr (1) · Anna D'Angelo (1) · Anna Wu (1) · Beatriz Adrada, MD (1) · Bruce Schroeder, MD (1) · Carol J Fabian (1) · Chen-Pin Chou, MD (1)
PMID 35103537, PMID 11936199, PMID 12642576, PMID 15585733, PMID 15599396, PMID 15960763, PMID 15961755, PMID 15985467, PMID 16169887, PMID 16180227, PMID 16373758, PMID 16878575, PMID 16878576, PMID 17384585, PMID 17459484, PMID 17617273, PMID 17890212, PMID 18227537, PMID 18372463, PMID 18490686, PMID 19079345, PMID 19509223, PMID 19770804, PMID 20055701, PMID 20304629, PMID 20623382, PMID 21139507, PMID 21421848, PMID 21502382, PMID 21765444, PMID 22098854, PMID 22493518, PMID 23018442, PMID 23114846, PMID 24401642, PMID 24448363, PMID 24953385, PMID 25042234, PMID 25148175, PMID 25195735, PMID 25294086, PMID 25328522, PMID 25362204, PMID 25460336, PMID 25668012, PMID 26093959, PMID 26276750, PMID 26709819, PMID 27069189, PMID 27353417
UG1CA242632 (3), P30CA046592 (2), U10CA180888 (2), P30CA014089 (1), P30CA060553 (1), R01CA142575 (1), R01CA181081 (1), R01CA187595 (1), U01CA079778 (1), U01CA080098 (1), U10CA037447 (1), UG1CA189828 (1), UG1CA242596 (1), UG1CA242609 (1), UG1CA242635 (1)